Infection Viral Clinical Trial
Official title:
Surveillance of Nosocomial Influenza at Edouard Herriot University Hospital, Lyon, France
Hospital-Acquired Influenza (HAI) is closely linked to the intensity of influenza in the community. HAI is associated with significant morbidity, mortality and extra costs due to prolonged hospital stay. The incidence of laboratory confirmed HAI has been reported rarely. The proportion of HAI among influenza cases was 11.38% (95% Confidence Interval: 5.19%-19.55%) in a meta-analysis of 14 studies. In France, a prospective surveillance study of adults with Influenza-Like Illness (ILI) over 11 years, reported that 35.6% of the influenza cases diagnosed at hospital were hospital-acquired. HAI is transmitted via respiratory droplets and by hand contacts. The spread is facilitated by Health Care Professionals (HCPs), patients and visitors. Prevention and control of HAI is of upmost importance to preserve patient safety and limit the related economic costs. While vaccination of HCPs has been shown to contribute to the reduction of HAI, less is known on the impact of patient vaccination on the risk of HAI during hospitalization. The aim of this study is to describe the hospital-acquired influenza in a french university hospital.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06178822 -
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
|
||
| Completed |
NCT05041764 -
RNA Sequencing of Individual Versus Wastewater - SARS-CoV2
|
||
| Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
| Recruiting |
NCT03818334 -
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
|
Phase 2/Phase 3 | |
| Completed |
NCT04637867 -
COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO)
|
N/A | |
| Recruiting |
NCT06149494 -
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
|
Phase 2 | |
| Completed |
NCT05069623 -
A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04386460 -
Covid-19 and Prevention of Malnutrition After Confinement by Dentists
|
||
| Not yet recruiting |
NCT06379061 -
Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts
|
||
| Completed |
NCT04290780 -
COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus
|
||
| Completed |
NCT04327180 -
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
|
||
| Recruiting |
NCT04438629 -
Evaluation of Immune Response in COVID-19 Patients
|
||
| Active, not recruiting |
NCT05874713 -
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults
|
Phase 2 | |
| Completed |
NCT03163628 -
biomArkers to differeNtiate bacTerial From vIral iNfEctions
|
N/A | |
| Completed |
NCT04924842 -
COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2)
|
||
| Completed |
NCT04354155 -
COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial
|
Phase 2 | |
| Recruiting |
NCT05875961 -
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults
|
Phase 1 | |
| Active, not recruiting |
NCT04481529 -
COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector
|
||
| Recruiting |
NCT05090319 -
Micro-hematology Analyzer for Viral/Bacterial Description
|
||
| Not yet recruiting |
NCT04887233 -
Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19)
|
N/A |